Retinopathy of Prematurity, Pain Management, BIUMS, Dr Joobin Khadamy, 1st feb 2018
It review current approach in management of pain during retinopathy of prematurity screening.
Retinopathy of prematurity, Therapy Modalities, BIUMS, Dr Joobin Khadamy, 1st...Joobin Khadamy . MD
Retinopathy of Prematurity, Pain Management, BIUMS, Dr Joobin Khadamy, 1st feb 2018
It review current available therapies and future of therapy in management of retinopathy of prematurity.
Retinopathy of prematurity (ROP), initially described as retrolental fibroplasia one of the leading cause of blindness in children.
Despite advances in diagnosis and treatment, as medicine and technology advances and premature infants are surviving at earlier gestational ages, ROP continues to be a significant problem.
ROP results in disorganized growth of retinal blood vessels, which may lead to scarring and retinal detachment.
Retinopathy of prematurity, Therapy Modalities, BIUMS, Dr Joobin Khadamy, 1st...Joobin Khadamy . MD
Retinopathy of Prematurity, Pain Management, BIUMS, Dr Joobin Khadamy, 1st feb 2018
It review current available therapies and future of therapy in management of retinopathy of prematurity.
Retinopathy of prematurity (ROP), initially described as retrolental fibroplasia one of the leading cause of blindness in children.
Despite advances in diagnosis and treatment, as medicine and technology advances and premature infants are surviving at earlier gestational ages, ROP continues to be a significant problem.
ROP results in disorganized growth of retinal blood vessels, which may lead to scarring and retinal detachment.
Apart from its established role in Age related maculopathy, Ani-Vegf have other usage too. Presently clinical study reports are coming in showing encouraging results.
Comparative study of the results of 0.04%da mitomycin c and simple conjunctiv...Apollo Hospitals
Pterygium recurrence is one of the most common complications following simple pterygium excision. Mitomycin-C and conjunctival autograft are the two procedures known to decrease the recurrence rate. Comparing the results of the two procedures is the purpose of this study.
Purpose: We report a rare case of a 2 - year-old child with ectopia lentis and potential Marfan syndrome (MFS) and discuss her management.
Methods: A 2 - year - old female with no signifi cant past medical history was brought in by her mother after complaints that the child has recently been holding everything close to her eyes while simultaneously shifting her head down. Her mother reported no history of pain or trauma. The child’s family history was negative for ectopia lentis or MFS.
Apart from its established role in Age related maculopathy, Ani-Vegf have other usage too. Presently clinical study reports are coming in showing encouraging results.
Comparative study of the results of 0.04%da mitomycin c and simple conjunctiv...Apollo Hospitals
Pterygium recurrence is one of the most common complications following simple pterygium excision. Mitomycin-C and conjunctival autograft are the two procedures known to decrease the recurrence rate. Comparing the results of the two procedures is the purpose of this study.
Purpose: We report a rare case of a 2 - year-old child with ectopia lentis and potential Marfan syndrome (MFS) and discuss her management.
Methods: A 2 - year - old female with no signifi cant past medical history was brought in by her mother after complaints that the child has recently been holding everything close to her eyes while simultaneously shifting her head down. Her mother reported no history of pain or trauma. The child’s family history was negative for ectopia lentis or MFS.
SMi’s 17th annual Pain Therapeutics conference will hone in on the latest innovations and novel approaches to pain therapy and analgesic drugs as well as look at the practicalities of using animal models and translational biomarkers in pain research. Aimed at an audience of senior specialists in neurology, CNS, clinical sciences and pharmacology, Pain Therapeutics 2017 will keep attendees at the forefront of scientific breakthroughs to adapt to the growing need towards minimising opioid dependency and new drug discovery. Presentations from a selection of leading pharmaceutical companies currently developing novel analgesic treatments including Nektar Pharmaceuticals, Janssen, MSD USA, Grunenthal GmbH, Lilly UK and Mundipharma, will provide delegates with an understanding on key topics such as product formulation; opioid addiction; translational pain research; and breakthroughs in drug discovery.
University of Utah Health Improving Wellness: 40 Champions, 20 Projects, 12 M...University of Utah
On December 14, 2017, the Wellness & Integrative Health’s Resiliency Center, Accelerate, and the Spencer S. Eccles Health Sciences Library will presented a Faculty Wellness Poster Session. Each department in the School of Medicine highlighted the past year’s Wellness Champion projects, which were focused on personal resilience, burden reduction, and team work. The poster session demonstrated the work completed so far as the Wellness Champion program is expanded to faculty and staff across U of U Health.
University of Utah Health: Wellness Champion Poster Session 2017University of Utah
Improving Wellness: 40 Champions, 20 Projects and 12-months of Progress: The Wellness and Integrative Health’s Resiliency Center, Accelerate, and the Spencer S. Eccles Health Sciences Library presented a Faculty Wellness Poster Session. Each department in the School of Medicine highlighted the past year’s Wellness Champion projects, which are focused on personal resilience, burden reduction, and team work. The poster session demonstrates work completed so far as the Wellness Champion program is expanded to faculty and staff across U of U Health.
Similar to Retinopathy of Prematurity, Pain Management, BIUMS, Dr Joobin Khadamy, 1st feb 2018 (20)
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Retinopathy of Prematurity, Pain Management, BIUMS, Dr Joobin Khadamy, 1st feb 2018
1. PA I N M A N A G E M E N T
RETINOPATHY OF
PREMATURITY
ROP Conference; Birjand University of Medical science (BIUMS)
Joobin Khadamy MD
1/Feb/2018
2. INTRODUCTION
• The most vulnerable infants, with the highest burden of pain,
are those born prematurely who require intensive neonatal
care.
• Retinopathy of Prematurity (ROP) screening is an example of
a highly invasive medical procedure that is repeatedly
performed on premature infants.
• Stress or pain caused during exam may contribute to apnea(up
to 41%) and bradycardia events during and after the exam.
Wade KC, Pistilli M, Baumritter A, et al. Safety of ROP Examination and imaging in Premature Infants. The Journal of pediatrics.
2015;167(5):994-1000.e2. doi:10.1016/j.jpeds.2015.07.050.
3. INTRODUCTION
• Unfortunately, ROP screening is considered to be painful and
stressful for both infants and parents!
• CRIES pain score was significantly higher 5 min after and 24
h after the screening procedure than before.
screening for retinopathy of prematurity: is it painful? [Biol Neonate. 2006]
4. INTRODUCTION
• Unfortunately, ROP screening is considered to be painful and
stressful for both infants and parents!
• CRIES pain score was significantly higher 5 min after and 24
h after the screening procedure than before.
screening for retinopathy of prematurity: is it painful? [Biol Neonate. 2006]
5. INTRODUCTION
• EVEN MYDRIATIC DROP REPORTED TO BE PAINFUL!
• But most painful part is related to eyelids speculum!
Cohen, Amy M. et al. “The Pain Response to Mydriatic Eye Drops in Preterm Infants.” Journal of perinatology : official journal of the
California Perinatal Association 33.6 (2013): 462–465. PMC. Web. 11 Mar. 2017.
6. PAIN
ASSESSMENT
• Behavioural > GOLD STANDARD
• Premature Infant Pain Profile (PIPP)
• Electrophysiological techniques
• nociceptive-specific brain activity and reflex withdrawal activity
Slater R, Hartley C, Moultrie F, et al. A blinded randomised placebo-controlled trial investigating the efficacy of morphine analgesia for
procedural pain in infants: Trial protocol. Wellcome open research. 2016;1:7. doi:10.12688/wellcomeopenres.10005.1.
7. PAIN MANAGEMENT
STRATEGIES
1) Nonpharmacological interventions
2) Topical eye anesthetics
3) Eye examination techniques
Da Costa, Marlene Coelho et al. “Oral Glucose for Pain Relief during Examination for Retinopathy of Prematurity: A Masked
Randomized Clinical Trial.” Clinics 68.2 (2013): 199–203. PMC. Web. 11 Mar. 2017.
8. NON-PHARMACOLOGICAL
INTERVENTIONS
a) Use of sucrose or oral glucose (effective)
b) With swaddle (effective)
c) Nonnutritive sucking (effective)
d) Human milk (comparable to sucrose)
e) Use of the Newborn Individualized Developmental Care and
Assessment Program (NIDCAP)
Da Costa, Marlene Coelho et al. “Oral Glucose for Pain Relief during Examination for Retinopathy of Prematurity: A Masked
Randomized Clinical Trial.” Clinics 68.2 (2013): 199–203. PMC. Web. 11 Mar. 2017.
9. PHARMACOLOGICAL
INTERVENTIONS
• Topical/local anesthetics (in consistent effect)
• Paracetamol (ineffective)
• Morphine?
• Fentanyl infusion safer than morphine in laser therapy
Da Costa, Marlene Coelho et al. “Oral Glucose for Pain Relief during Examination for Retinopathy of Prematurity: A Masked
Randomized Clinical Trial.” Clinics 68.2 (2013): 199–203. PMC. Web. 11 Mar. 2017.
10. IMAGING VS. INDIRECT
OPHTHALMOSCOPE
• A transient short-term pain and stress response occurs with
both
• Digital retinal imaging ( less pain and stress at 30 seconds but
longer examination time).
Moral-Pumarega MT, Caserío-Carbonero S, De-La-Cruz-Bértolo J, Tejada-Palacios P, Lora-Pablos D, Pallás-Alonso CR. Pain and
stress assessment after retinopathy of prematurity screening examination: Indirect ophthalmoscopy versus digital retinal imaging.
BMC Pediatrics. 2012;12:132. doi:10.1186/1471-2431-12-132.
11. PAIN MANAGEMENT STRATEGIES
• A recent Cochrane review examining the use of local
anaesthetic concluded that
• “Screening remains a painful procedure and the role of non-
pharmacological and pharmacological intervention including
different local anaesthetic agents should be ascertained in
future randomised trials”.
• Effective pain relief may reduce physiological instability
Local anaesthetic eye drops for prevention of pain in preterm infants undergoing screening for retinopathy of prematurity.Dempsey E,
McCreery K Cochrane Database Syst Rev. 2011 Sep 7; (9):CD007645.
12. FUTURE STUDIES
• The efficacy and use of techniques is not adequate!
• Further investigation of pain management techniques may
relief parents and infant stress.
• Investigating the clinical feasibility of an eye examination
without speculum use may be beneficial for this population.
13. IMPORTANT NOTES
• Use multiple strategies
• Protocols should address:
• timing of mydriatic eye drops
• feeding times
• Examination times at schedules
10.1097/ANC.0000000000000267 :What Is Best Practice for Providing Pain Relief During Retinopathy of Prematurity Eye Examinations?